RxDoctor Payments DataLook up a doctor →

Anthony Emmer, DO

Neurology · Southfield, MINPI 1003819897

Payments from drug & device makers

$173,170in general payments, 2019–2025

Across 2,462 payments — averaging $70.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$71K
  • Impel Pharmaceuticals Inc.$35K
  • Sanofi$16K
  • Pfizer$9K
  • EMD Serono, Inc.$5K
  • Novartis$4K
  • plus $33K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)265$71,309
Impel Pharmaceuticals Inc.59$34,759
Sanofi100$15,705
Pfizer44$8,689
EMD Serono, Inc.136$4,756
Novartis266$3,581
Biogen84$3,414
UCB, Inc.168$2,634
Teva Pharmaceuticals USA, Inc.133$2,278
Catalyst Pharmaceuticals, Inc.12$1,769
AstraZeneca(2 entities)65$1,424
Amgen(2 entities)63$1,391
Lilly USA, LLC78$1,367
Neurocrine Biosciences, Inc.54$1,111
Bristol Myers Squibb65$1,041
Banner Life Sciences, LLC7$1,033
TG Therapeutics, Inc.34$933
Genentech USA, Inc.43$795
Alnylam Pharmaceuticals Inc.49$769
Lundbeck LLC30$686
Eisai Inc.29$650
Johnson & Johnson30$646
Argenx US, Inc.28$629
Acadia Pharmaceuticals Inc26$596
Avanir Pharmaceuticals, Inc.35$574
Acorda Therapeutics, Inc32$564
SK Life Science, Inc.25$557
Neurelis, Inc.34$552
Kyowa Kirin, Inc.22$516
Scilex Pharmaceuticals Inc.27$505
Takeda Pharmaceuticals U.S.A., Inc.26$421
Jazz Pharmaceuticals Inc.16$382
Sumitomo Pharma America, Inc.19$349
CSL Behring17$339
MDD US Operations, LLC22$332
ANI Pharmaceuticals, Inc.16$323
E.r. Squibb & Sons, L.L.C.12$323
Sunovion Pharmaceuticals Inc.19$306
Upsher-smith Laboratories LLC15$300
Vanda Pharmaceuticals Inc.13$296
Biohaven Pharmaceuticals, Inc.14$293
Amneal Pharmaceuticals LLC15$281
Axsome Therapeutics, Inc.16$253
Otsuka America Pharmaceutical, Inc.14$247
Supernus Pharmaceuticals, Inc.13$212
Corium, LLC12$212
Biohaven Pharmaceutical Holding Company Ltd.10$199
Adamas Pharmaceuticals, Inc.13$187
Harmony Biosciences LLC8$170
Grifols USA, LLC7$160
Mallinckrodt Hospital Products Inc.10$160
Tanabe Pharma America, Inc.8$157
Validus Pharmaceuticals LLC7$128
Cycle Pharmaceuticals Inc6$126
Octapharma USA, Inc.5$121
Sanofi-aventis U.S. LLC2$112
Akcea Therapeutics, Inc.6$99
Greenwich Biosciences, Inc.2$99
Aquestive Therapeutics, Inc.5$95
Cala Health, Inc.6$93

How this compares

$173,170 in reported general payments places this provider in the 90th percentile of 652 neurology providers in Michigan.

See all neurology providers in Michigan

Medicare billing

Part B allowed, 2024
$367,399
Medicare patients
873
Services billed
13,199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Southfield

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →